Finding that could shed light on 'golden staph,' candida and allergies

Recent scientific findings explain why patients with a rare immunodeficiency disorder are unusually susceptible to certain common infections. By revealing the exact molecular mechanisms involved, they also give us clues as to why some 'healthy' people are more prone to these infections than others, and suggest potential treatments.

People with Hyper IgE Syndrome, or 'Job's Syndrome', suffer from devastating complications of skin, gut and lung infections caused by candida albicans and Staphylococcus aureus. We all have these fungi and bacteria on our skin, but healthy immune systems largely keep them at bay.

Late last year, research groups in Japan, Europe and the United States discovered that Hyper IgE Syndrome is caused by a mutation in the Stat3 gene. Although the gene was identified, the mechanisms leading to illness were not determined.

The Stat3 finding led Scientists at Sydney's Garvan Institute for Medical Research and Canberra's John Curtin School of Medical Research to speculate that patients with Job's syndrome lack a subset of immune cells known as Th17 cells.

Laboratory tests conducted by Dr Cindy Ma, a postdoctoral researcher at Garvan, and Drs Gary Chew and Nicholas Simpson at the John Curtin School confirmed the hypothesis, leading to publication of a paper online today in the Journal of Experimental Medicine.

"We've established that patients with Hyper IgE Syndrome are deficient in a particular subset of immune cells that are important in protecting the normal population against candidal and staphylococcal infections," said Dr Stuart Tangye, head of Garvan's Immunobiology research group. "Now that we understand the mechanisms behind the illness, it should not take long to develop a treatment. There is also the prospect of treating other diseases which cause susceptibility to candida."

Dr Matthew Cook, Immunologist at Canberra Hospital, medical researcher at John Curtin and together with Stuart Tangye, co-senior author on the project, has much first-hand experience with Hyper IgE syndrome. Of the five patients examined in this study, three came from his clinic. "While Job's syndrome is a very rare disease – roughly one in 500,000 – for individuals affected, the consequences are devastating, and until now we have had very little idea about how to manage the complications. Our findings offer the potential of rational and effective treatment in the future."

"People with Job's syndrome suffer from a narrow spectrum of infections that can be life-threatening, including lung infections that result in chronic lung damage. They are also susceptible to skeletal disorders including osteoporosis and frequent bone fractures. There are currently about 12 people diagnosed with the syndrome in Australia and around 80 being treated by the National Institutes of Health in the U.S."

"Since Job's syndrome is characterised by very high levels of IgE, the antibodies crucial for allergic responses, understanding the connection between the absence of Th17 immune cells and presence of IgE is a high priority for future research that might shed light on other common disorders."

Source: Research Australia

Related stories:

People with Job's syndrome lack specific immune cells
Scientists have made another major breakthrough--the second in the past year--in understanding a rare immune disorder called Job’s syndrome. Job’s syndrome is characterized by recurrent and often severe bacterial and fungal infections leading to outbreaks of abscesses and boils. Other symptoms of the disease include lung infections, problems in facial and dental development, curved spine and high risk of bone fractures. While individuals with Job’s syndrome often have normal life spans with intensive medical supervision, life-threatening complications from infections are a constant concern.
Researchers propose minocycline as a promising drug for patients with Fragile X syndrome
A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism.
Probiotic bacteria can induce monocyte-derived dendritic cells maturation?
Probiotic bacteria are widely used to relieve the symptoms of many disorders such as inflammatory bowel syndrome, diarrhea, and allergies. Probiotic mixtures have also been found to reduce the symptoms of diarrhea. In children a probiotic bacterium L. rhamnosus GG has been shown to prevent the onset of atopy and allergies. However, the mechanisms that cause these beneficial actions are yet to be characterized. One of the factors contributing to the health promoting effects of probiotic bacteria could be their capacity to induce cytokine production that further regulates the development of innate and adaptive immune responses.
Deep brain stimulation offers hope to people with treatment-resistant illnesses
Every day during a four-year deep depression, Sean Miller thought of ending his life. Nothing relieved the emotional darkness - not therapy, not medication, not loving attention from family and friends.
Virus weaves itself into the DNA transferred from parents to babies
Parents expect to pass on their eye or hair color, their knobby knees or their big feet to their children through their genes. But they don't expect to pass on viruses through those same genes.
New study shows health benefits of probiotic could extend to the entire body
Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. Gastrointestinal benefits of probiotics have been well-documented, but more and more research is revealing that probiotic benefits extend to the entire body. The report was published in the August issue of the Public Library of Science (PLoS) Pathogens.
How flesh-eating bacteria attack the body's immune system
"Flesh-eating" or "Strep" bacteria are able to survive and spread in the body by degrading a key immune defense molecule, according to researchers at the University of California, San Diego, School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences. The finding, which could aid in development of new treatments for serious infections in human patients, will be reported in the August 14 issue of the journal Cell Host & Microbe.
UC San Diego Medical Center Studies Mystery of Mother's Milk
“Breast is best” is a mantra every new mom hears with when it comes to feeding her newborn. Human milk is known to boost brain development, prevent life-threatening infections, decrease allergies, and promote stronger bones and a higher IQ. But what’s a mother to do when her premature infant weighs only ounces and is not able to swallow the milk?

News discussion:

Medicine & Health news